课题基金 / 基金详情

CORE--PROTOCOL SPECIFIC RESEARCH

CORE--PROTOCOL SPECIFIC RESEARCH
核心——协议特定研究
批准号:
6989610
负责人:
KENNETH A FOON
金额:
$8.8万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-22 至 2009-07-31

项目摘要

项目成果

KENNETH A FOON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A primary goal of the clinical trials efforts of UPCI is to design, implement and analyze innovative, investigator-initiated phase I and II clinical trials. The dcvelopment, initiation, implementation and completion of UPCI investigational studies receive substantial and essential support from UPCI Clinical Research Services (CRS). The assigned clinical research coordinators are involved in study design and implementation, design of study schema, forms design, patient education and compliance, collection, handling and shipping of specimens, collection and entry of data and keeping the principal investigator informed of all patient and research issues. UPCI has made noteworthy advances, in innovative pilot and phase I studies in the last 5 years, in several programs including Molecular Therapeutics and Drug Discovery, Biological Therapeutics, Prostate and Urologic Cancers, Head and Neck Cancer, Immunology, and breast cancer. The PSRC is utilized by UPCI members from all of these and other programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTIIDIOTYPE VACCINE WITH IL2 FOR ADVANCED MELANOMA
  • 批准号:
    2717588
  • 项目类别:
  • 资助金额:
    $4.14万
  • 财政年份:
    1998
  • 负责人:
    KENNETH A FOON
  • 依托单位:
SOUTHWEST ONCOLOGY GROUP
  • 批准号:
    2856486
  • 项目类别:
  • 资助金额:
    $3.74万
  • 财政年份:
    1998
  • 负责人:
    KENNETH A FOON
  • 依托单位:
SOUTHWEST ONCOLOGY GROUP
  • 批准号:
    6137642
  • 项目类别:
  • 资助金额:
    $4.06万
  • 财政年份:
    1998
  • 负责人:
    KENNETH A FOON
  • 依托单位:
ANTIIDIOTYPE VACCINE WITH IL2 FOR ADVANCED MELANOMA
  • 批准号:
    2896729
  • 项目类别:
  • 资助金额:
    $3.31万
  • 财政年份:
    1998
  • 负责人:
    KENNETH A FOON
  • 依托单位:
海外基金